Shares of ResMed Inc. RMD slumped 0.35% to $228.69 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Morgans analyst Iain Wilkie said 2024 was "pretty patchy" for the ASX healthcare sector, which underperformed broader markets ...

These 2 ASX shares are set to deliver a strong set of earnings in the next quarter according to experts. Let's dive in.